INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹10 Cr | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.97 Cr |
| Mar2022 | ₹8.10 Cr |
| Mar2021 | ₹5.27 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | -2.66 | |
| Mar2024 | ₹11 Cr | 19.34 | |
| Mar2023 | ₹8.97 Cr | 10.73 | |
| Mar2022 | ₹8.10 Cr | 53.68 | |
| Mar2021 | ₹5.27 Cr | - | |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹162.8 Cr | -0.5% | -9.1% | -53.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,057.3 Cr | 2.3% | -7.5% | -26.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,136.8 Cr | -2.9% | 1.1% | 2.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,075.1 Cr | -1.3% | -1% | -3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹944.5 Cr | 4.5% | -1.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹469.0 Cr | -4.3% | -15% | -10.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.5% |
-9.1% |
-53.5% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses